Skip to content
Latest News
B&M Share Price Target Raised — Will it Benefit From Trade Down?

B&M European Retail Value (LON: BME) shares are down 35% in 2022, but on Monday, one analyst upped his price target on the stock. JPM

Sam Boughedda
Ashtead Technology Acquires Hiretech For £20m

Ashtead Technology (LON: AT.) announced Monday that it has acquired Hiretech Limited in a £20 million deal. The Aberdeenshire-based equip

Sam Boughedda
EURUSD Price: Euro Rises As Russian Oil Restrictions Kick-Off

The EURUSD currency pair was trading up slightly during the American session after giving up some of its earlier gains. The pair had benefited significantly from the risk-on market sentiment during the Asian session when it h

Simon Mugo
TOP SHIPS (TOPS) Stock Crashed 60%+ on a $13.5M Capital Raise

The  TOP SHIPS Inc (NASDAQ: TOPS) stock price crashed 60.81% after announcing that it had raised $13.5 million by placing 6.75 million units priced at $2 each. Investors reacted negatively to the capital raise due to the sign

Simon Mugo
Cosmos Holdings (COSM) Stock Rallied 29% Premarket. Here’s Why

The Cosmos Holdings Inc (NASDAQ: COSM) stock price rallied 29.3% during premarket trading as investor interest in the stock remained high following two crucial announcements made last week on Tuesday and Friday.

Simon Mugo
Royal Mail (IDS) Shares Face Bleak Future As Strikes Continue

The Royal Mail share price, now known as International Distributions Services PLC (LON: IDS), faces an uncertain future as the Communication Workers Union (CWU) forges ahead with its strikes planned for 9, 11, 14, 15, 23 and

Simon Mugo
Coinbase Share Price Target Cut at Atlantic Equities —FTX Collapse Could Be Event That ‘Extends’ Crypto Winter

Coinbase's (NASDAQ: COIN) share price target was cut to $46 from $67 per share at Atlantic Equities on Monday by analyst Simon Clinch. Th

Sam Boughedda
Cineworld Shares Rise Following Latest Update — Here’s Why

The Cineworld Group plc (LON: CINE) share price rose 3.53% after the company stated that it intends to emerge from the ongoing court-supervised chapter 11 bankruptcy proceedings largely unscathed.

Simon Mugo
Bitcoin and Ether Basing and Bullish Price Forecasts

The major cryptocurrencies have been in a more positive phase since mid-November, despite the negative price action seen since early November, with the fallout from the

Steve Miley
Fisker Denied Short Report Claims of Magna Bank Guarantee

Last week Thursday, Fisker (NYSE: FSR) shares fell more than 5% after the short-selling firm Fuzzy Panda took aim at the company, its founders, and their contract manufacturer, Magna, in a 

Sam Boughedda
Which Companies Are Announcing UK Earnings This Week — December 5

Names such as Berkeley Group (LON: BKG), Moonpig (LON: MOON), Frasers Group (LON: FRAS), and Purplebricks (LON: PURP) are set to post updates this week.

AskTraders Team
Equals Group Shares Jump On Robust Revenue Growth

Equals Group (LON: EQLS) shares jumped Monday morning after the company released a trading update, telling investors that revenue growth "remains robust" despite unfavourable global macroeconomic conditions.

Sam Boughedda
Apple Speeds Up Plans to Move iPhone Production Out of China

Apple (NASDAQ: AAPL) is reportedly speeding up its plans to shift iPhone production away from China following worker protests as a result of Covid regulations at the largest iPhone factory in the world.

Sam Boughedda
Vodafone Shares Rise as CEO to Step Down

Vodafone (LON: VOD) announced early Monday that the company's Chief Executive Officer, Nick Read, has agreed to step down on December 31.

Sam Boughedda
US Dollar Index Surges on Nonfarm Payroll Data. What’s Next?

The US Dollar Index today surged 85 pips higher following the release of upbeat nonfarm payroll data, which showed that the country created 263,000 new jobs, beating analysts' estimates of 200,000 new jobs.

Simon Mugo
Anavex Life (AVXL) Stock Rallied 67.3% After Trial Met Endpoints

The Anavex Life Sciences Corp (NASDAQ: AVXL) stock price rallied 67.3% after releasing the phase 2b/3 clinical trial of its oral ANAVEX®2-73 (blarcamesine) for the treatment of mild cognitive impairment (MCI) due to

Simon Mugo
Polkadot Price Trying to Base, Upside Risks and Prediction

A push higher for Polkadot this week has sent a bullish, short-term, technical analysis signal on the chart. This price action sets the risk for a higher price forecast into December and maybe on into early 2023.

Steve Miley
Beam Therapeutics Shares Jump After FDA Lifts BEAM-201 Clinical Hold

Beam Therapeutics (NASDAQ: BEAM) shares have rallied premarket after the company revealed that the US Food and Drug Administration (FDA) has lifted the clinical hold for BEAM-201.

Sam Boughedda
Rigel Pharma (RIGL) Stock Soared 40% as FDA Approves New Drug

The Rigel Pharmaceuticals Inc (NASDAQ: RIGL) stock price soared 40.5% after the US Food and Drug Administration (FDA) approved its leukemia drug known as REZLIDHIA™ (olutasidenib).

Simon Mugo
Rio Tinto Downgraded to Neutral at Citi

Rio Tinto (LON: RIO) (NYSE: RIO) was downgraded to Neutral from Buy at Citi on Thursday following its Capital Markets Day event. Analyst

Sam Boughedda
Analysis Stocks Markets Strategies